• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人硫嘌呤S-甲基转移酶与6-巯基嘌呤模型复合物的分子动力学模拟

Molecular dynamics simulation of a human thiopurine S-methyltransferase complexed with 6-mercaptopurine model.

作者信息

Mokmak Wanwimon, Tongsima Sissades, Jenwitheesuk Ekachai

机构信息

National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, 113 Thailand Science Park, Phahonyothin Road, Klong 1, Klongluang, Pathumthani 12120, Thailand.

出版信息

Bioinformation. 2009 Sep 5;4(2):59-62. doi: 10.6026/97320630004059.

DOI:10.6026/97320630004059
PMID:20198169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2823381/
Abstract

Human thiopurine S-methyltransferase (TPMT) is an essential protein in 6-mercaptopurine (6MP) drug metabolism. To understand the pharmacogenetics of TPMT and 6MP, X-ray co-crystal structures of TPMT complexes with S-adenosyl-L-methionine (AdoMet) and 6MP are required. However, the co-crystal structure of this complex has not been reported because 6MP is poorly water soluble. We used molecular dynamics (MD) simulation to predict the structure of the complex of human TPMT-AdoHcy(CH(2))6MP, where the sulfur atoms of AdoHcy and 6MP were linked by a CH(2) group. After 1300 picoseconds of MD simulation, the trajectory showed that 6MP was stabilized in the TPMT active site by formation of non-bonded interactions between 6MP and Phe40, Pro196 and Arg226 side chains of TPMT. The intersulfur distance between AdoHcy and 6MP as well as the binding modes and the interactions of our TPMT-AdoHcy model are consistent with those observed in the X-ray crystal structure of murine TPMT-AdoHcy-6MP complex. The predicted binding modes of AdoHcy and 6MP in our model are consistent with those observed in murine TPMT X-ray crystal structures, which provides structural insights into the interactions of TPMT, AdoHcy, and 6MP at the atomic level and may be used as a starting point for further study of thiopurine drug pharmacogenetics.

摘要

人硫嘌呤 S - 甲基转移酶(TPMT)是 6 - 巯基嘌呤(6MP)药物代谢中的一种重要蛋白质。为了解 TPMT 和 6MP 的药物遗传学,需要 TPMT 与 S - 腺苷 - L - 甲硫氨酸(AdoMet)和 6MP 复合物的 X 射线共晶体结构。然而,由于 6MP 的水溶性较差,该复合物的共晶体结构尚未见报道。我们使用分子动力学(MD)模拟来预测人 TPMT - AdoHcy(CH(2))6MP 复合物的结构,其中 AdoHcy 和 6MP 的硫原子通过一个 CH(2) 基团相连。经过 1300 皮秒的 MD 模拟,轨迹显示 6MP 通过与 TPMT 的 Phe40、Pro196 和 Arg226 侧链形成非键相互作用而稳定在 TPMT 活性位点。我们的 TPMT - AdoHcy 模型中 AdoHcy 和 6MP 之间的硫间距离以及结合模式和相互作用与在小鼠 TPMT - AdoHcy - 6MP 复合物的 X 射线晶体结构中观察到的一致。我们模型中预测的 AdoHcy 和 6MP 的结合模式与在小鼠 TPMT X 射线晶体结构中观察到的一致,这为 TPMT、AdoHcy 和 6MP 在原子水平上的相互作用提供了结构见解,并可作为进一步研究硫嘌呤类药物药物遗传学的起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/c6495a349d85/97320630004059F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/0de9d99913df/97320630004059F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/cb365115906e/97320630004059F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/c6495a349d85/97320630004059F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/0de9d99913df/97320630004059F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/cb365115906e/97320630004059F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d1c/2823381/c6495a349d85/97320630004059F3.jpg

相似文献

1
Molecular dynamics simulation of a human thiopurine S-methyltransferase complexed with 6-mercaptopurine model.人硫嘌呤S-甲基转移酶与6-巯基嘌呤模型复合物的分子动力学模拟
Bioinformation. 2009 Sep 5;4(2):59-62. doi: 10.6026/97320630004059.
2
Structural basis of substrate recognition in thiopurine s-methyltransferase.硫嘌呤S-甲基转移酶底物识别的结构基础
Biochemistry. 2008 Jun 10;47(23):6216-25. doi: 10.1021/bi800102x. Epub 2008 May 17.
3
Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.硫嘌呤类药物治疗儿童白血病:遗传性硫嘌呤甲基转移酶活性对药物代谢和细胞毒性的影响。
Br J Clin Pharmacol. 1997 Nov;44(5):455-61. doi: 10.1046/j.1365-2125.1997.t01-1-00607.x.
4
Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.6-巯基嘌呤对骨髓干细胞的潜在致癌作用:与硫嘌呤代谢的关系。
Cancer. 1999 Sep 15;86(6):1080-6. doi: 10.1002/(sici)1097-0142(19990915)86:6<1080::aid-cncr26>3.0.co;2-5.
5
Thiopurine methyltransferase: a review and a clinical pilot study.硫嘌呤甲基转移酶:综述与临床初步研究
J Chromatogr B Biomed Appl. 1996 Mar 29;678(1):15-22. doi: 10.1016/0378-4347(95)00432-7.
6
Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia.大剂量6-巯基嘌呤和甲氨蝶呤输注对急性淋巴细胞白血病巩固治疗期间转甲基作用的影响。
Biochem Pharmacol. 1996 May 3;51(9):1165-71. doi: 10.1016/0006-2952(96)00032-9.
7
Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies.儿童淋巴细胞白血病中的硫嘌呤甲基转移酶缺乏症:6-巯基嘌呤的剂量策略。
Med Pediatr Oncol. 1997 Oct;29(4):252-5. doi: 10.1002/(sici)1096-911x(199710)29:4<252::aid-mpo3>3.0.co;2-l.
8
Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.甘氨酸N-甲基转移酶的自动抑制和强制产物释放机制:野生型、突变体R175K以及结合S-腺苷同型半胱氨酸的R175K酶的晶体结构
J Mol Biol. 2000 Apr 21;298(1):149-62. doi: 10.1006/jmbi.2000.3637.
9
Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.
Br J Haematol. 1999 Jun;105(3):696-700. doi: 10.1046/j.1365-2141.1999.01416.x.
10
Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.硫嘌呤S-甲基转移酶药物遗传学:变异等位基因的功能与比较基因组学
Pharmacogenet Genomics. 2005 Nov;15(11):801-15. doi: 10.1097/01.fpc.0000174788.69991.6b.

引用本文的文献

1
Molecular Dynamics and Docking Simulations of Homologous RsmE Methyltransferases Hints at a General Mechanism for Substrate Release upon Uridine Methylation on 16S rRNA.同源 RsmE 甲基转移酶的分子动力学和对接模拟提示了 16S rRNA 上尿嘧啶甲基化后底物释放的一般机制。
Int J Mol Sci. 2023 Nov 24;24(23):16722. doi: 10.3390/ijms242316722.
2
Epigenetic inheritance of DNA methylation changes in fish living in hydrogen sulfide-rich springs.富氢温泉中生活的鱼类 DNA 甲基化变化的表观遗传遗传。
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). doi: 10.1073/pnas.2014929118.
3
In Vitro Protein Stability of Two Naturally Occurring Thiopurine -Methyltransferase Variants: Biophysical Characterization of TPMT*6 and TPMT*8.

本文引用的文献

1
Structural basis of substrate recognition in thiopurine s-methyltransferase.硫嘌呤S-甲基转移酶底物识别的结构基础
Biochemistry. 2008 Jun 10;47(23):6216-25. doi: 10.1021/bi800102x. Epub 2008 May 17.
2
Structural basis of allele variation of human thiopurine-S-methyltransferase.人类硫嘌呤 - S - 甲基转移酶等位基因变异的结构基础
Proteins. 2007 Apr 1;67(1):198-208. doi: 10.1002/prot.21272.
3
The thiopurines: an update.硫嘌呤类药物:最新进展
两种天然存在的硫嘌呤甲基转移酶变体的体外蛋白质稳定性:TPMT*6和TPMT*8的生物物理特性
ACS Omega. 2017 Aug 31;2(8):4991-4999. doi: 10.1021/acsomega.7b00801. Epub 2017 Aug 28.
Invest New Drugs. 2005 Dec;23(6):523-32. doi: 10.1007/s10637-005-4020-8.
4
Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.硫嘌呤S-甲基转移酶药物遗传学:变异等位基因的功能与比较基因组学
Pharmacogenet Genomics. 2005 Nov;15(11):801-15. doi: 10.1097/01.fpc.0000174788.69991.6b.
5
The Amber biomolecular simulation programs.琥珀生物分子模拟程序。
J Comput Chem. 2005 Dec;26(16):1668-88. doi: 10.1002/jcc.20290.
6
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.SWISS-MODEL和Swiss-PdbViewer:一个用于比较蛋白质建模的环境。
Electrophoresis. 1997 Dec;18(15):2714-23. doi: 10.1002/elps.1150181505.
7
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.导致人硫嘌呤 S - 甲基转移酶催化活性丧失的单点突变。
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):949-53. doi: 10.1073/pnas.92.4.949.
8
A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.6-巯基嘌呤延迟性细胞毒性反应的生化机制。
Cancer Res. 1974 Apr;34(4):738-46.
9
Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.
Cancer Res. 1974 Apr;34(4):733-7.
10
The clinical pharmacology of 6-mercaptopurine.6-巯基嘌呤的临床药理学。
Eur J Clin Pharmacol. 1992;43(4):329-39. doi: 10.1007/BF02220605.